Europe
Eli Lilly has signed a collaboration deal with CureVac that could total up to $1.8B.
Net sales of DARZALEX in the third quarter of 2017 totaled USD 317 million.
Novartis is closing its generic-drug manufacturing facility in Broomfield, Colo., which will cut 450 jobs over two years.
Warp Drive Bio inked a strategic collaboration deal with Roche for up to $387M.
What are the risks and benefits of taking such a step? And what factors are important to consider before doing so?
PRESS RELEASES